Digestion
Original Paper
Human Alpha1-Microglobulin in Various Hepatic DisordersItoh Y. · Enomoto H. · Takagi K. · Kawai T. · Yamanaka T.Department of Clinical Pathology and Gastroenterology, Jichi Medical School, Tochigi, Japan
Keywords: α1-MicroglobulinLiver cirrhosisHepatoma |
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: November 12, 1982
Published online: January 28, 2009
Issue release date: 1983
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0
ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)
For additional information: https://www.karger.com/DIG
Abstract
Human α1-microglobulin (α1m) levels were studied in the sera and urine of patients with various liver diseases. In patients with acute hepatitis and chronic hepatitis it was almost within the normal range. A significant decrease of serum α1-m, however, was demonstrated in patients with compensated liver cirrhosis (p < 0.05) as well as in those with decompensated liver cirrhosis (p < 0.001). The most striking decrease was noted in patients with fulminant hepatitis (p < 0.001). Its concentration in hepatoma was generally within the normal range, but there was 1 hepatoma case with the high concentration of α1-m. Serum α1-m levels correlated significantly with serum albumin, plasma fibrinogen and cholinesterase activity. As compared with the level in normal individuals, the patients with decompensated liver cirrhosis had significantly low urinary α1-m (p < 0.005), reflecting the findings for sera. These results indicated that the liver plays an important role in α1m synthesis, and its quantitation may be used for evaluating severe liver damage.
© 1983 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: November 12, 1982
Published online: January 28, 2009
Issue release date: 1983
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0
ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)
For additional information: https://www.karger.com/DIG
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission